收藏切换
Research status on the effects and mechanism of phosphatidylethanolamine in atherosclerosis
收藏切换
PDF
Yuan-hong LIAO1a, Jing-kun LU1b, Jun LI1a, 1c, Xin TAN1b, Qiang WEI1b, Cheng-dong LIU1a, Ren BU1a, Yue-wu WANG1a, 1c
Chinese Journal of Clinical Pharmacology | 2025, 41(11) : 1614 - 1618
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(11): 1614-1618
Review
Research status on the effects and mechanism of phosphatidylethanolamine in atherosclerosis
Full
Yuan-hong LIAO1a, Jing-kun LU1b, Jun LI1a, 1c, Xin TAN1b, Qiang WEI1b, Cheng-dong LIU1a, Ren BU1a, Yue-wu WANG1a, 1c
Affiliations
  • 1a.School of Pharmacy, Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region, China
  • 1b.School of Basic Medicine, Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region, China
  • 1c.New Drug Screening Engineering Research Center, Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region, China
Published: 2025-06-17 doi: 10.13699/j.cnki.1001-6821.2025.11.020
Outline
收藏切换

Atherosclerosis (AS), a multifactorial inflammatory disease characterized by complex interactions among biomolecules and signaling pathways, poses significant cardiovascular risks. Emerging evidence highlights phosphatidylethanolamine (PE), a key phospholipid component of cellular membranes, as playing pivotal regulatory roles in both the initiation and progression of AS. While existing studies have elucidated PE’s fundamental biological functions, its precise molecular mechanisms governing inflammatory responses, lipid homeostasis, and signal transduction remain incompletely characterized. This comprehensive review systematically examines PE’s involvement in atherogenesis, explores its underlying pathophysiological mechanisms, and critically evaluates current research limitations alongside promising therapeutic avenues. Through this synthesis, we aim to advance mechanistic understanding of PE’s pleiotropic functions and inform novel intervention strategies for atherosclerotic cardiovascular diseases.

phosphatidylethanolamine  /  atherosclerosis  /  inflammatory response  /  lipid metabolism  /  cell signaling transduction
Yuan-hong LIAO, Jing-kun LU, Jun LI, Xin TAN, Qiang WEI, Cheng-dong LIU, Ren BU, Yue-wu WANG. Research status on the effects and mechanism of phosphatidylethanolamine in atherosclerosis[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (11) : 1614 -1618 . DOI: 10.13699/j.cnki.1001-6821.2025.11.020
Year 2025 volume 41 Issue 11
PDF
1
0
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.11.020
  • Receive Date:2024-12-27
  • Online Date:2026-08-04
  • Published:2025-06-17
Article Data
Affiliations
History
  • Received:2024-12-27
Funding
Affiliations
    1a.School of Pharmacy, Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region, China
    1b.School of Basic Medicine, Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region, China
    1c.New Drug Screening Engineering Research Center, Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.11.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT